Acceptance of Complementary Medicine in Germany

NCT ID: NCT05530720

Last Updated: 2024-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4505 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-19

Study Completion Date

2022-10-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Complementary medicine is widely practiced in Germany and worldwide. The aim of this study is to explore how many people use complementary medicine methods in Germany, for which health-related issues they do and for which they would not.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Population

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Online survey with 3.000 participants using mobile website technology

Cross-sectional survey

Intervention Type OTHER

No intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cross-sectional survey

No intervention.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent
* Age at least 18 years
* Sufficient language skills as well as cognitive ability to participate in an online survey or interview lasting approximately 30 minutes
* Active consent to the online consent form

Exclusion Criteria

\- Lack of consent to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Otto-Friedrich-University Bamberg, Chair of Sociology, Prof. Dr. Rasmus Hoffmann

UNKNOWN

Sponsor Role collaborator

Charite University, Berlin, Germany

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Christian S. Kessler

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Otto-Friedrich-University Bamberg

Bamberg, , Germany

Site Status

Charité Hochschulambulanz für Naturheilkunde, Immanuel Krankenhaus Berlin

Berlin, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Ortiz M, Wischnewsky M, Jeitler M, Brinkhaus B, Michalsen A, Hoffmann R, Kessler CS. Health-Related quality of life and the impact of traditional, complementary and integrative Medicine - an Online - Representative Cross-Sectional survey in Germany. BMC Public Health. 2025 Aug 21;25(1):2870. doi: 10.1186/s12889-025-23908-5.

Reference Type DERIVED
PMID: 40841634 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Complementary Medicine Survey

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Homeopathic Drug Proving Trial
NCT01061229 COMPLETED PHASE1